Literature DB >> 24438047

Neuroprotective effect of the proanthocyanidin-rich fraction in experimental model of spinal cord injury.

Lara Clemes Assis1, Mariana Appel Hort, Gisele Volpato de Souza, Alessandra Cadete Martini, Stefânia Forner, Daniel Fernandes Martins, Jenniffer Carolina Silva, Heros Horst, Adair Roberto Soares dos Santos, Moacir Geraldo Pizzolatti, Giles Alexander Rae, Janice Koepp, Andreza Fabro de Bem, Rosa Maria Ribeiro do Valle.   

Abstract

OBJECTIVES: In this study, we evaluated the effect of the proanthocyanidins-rich fraction (PRF) obtained from Croton celtidifolius bark in an experimental animal model of spinal cord injury and cell death induced by glutamate.
METHODS: Experiments were conducted using adult male Wistar rats (10 weeks old and weighing 270-300g). Experimental groups were randomly allocated into the following groups: spinal cord injury (SCI) + vehicle group: rats were subjected to SCI plus intraperitoneal administration of vehicle (saline 10 ml/kg); SCI + PRF: rats were subjected to SCI plus intraperitoneal administration of PRF (10 mg/kg) at 1 and 6 h after injury and sham operated. KEY
FINDINGS: The treatment with the proanthocyanidin-rich fraction significantly improved not only motor recovery and grip force but also H2 O2 or glutamate-induced cell death and reactive oxygen species generation induced by glutamate in dorsal root ganglion cells. In this study we demonstrate that the neuroprotective effect triggered by the proanthocyanidins-rich fraction appears to be mediated in part by the inhibition of N-methyl-D-aspartate-type glutamate receptors.
CONCLUSIONS: Taken together, our results demonstrate that PRF treatment ameliorates spinal cord injury and glutamatergic excitotoxicity and could have a potential therapeutic use.
© 2014 Royal Pharmaceutical Society.

Entities:  

Keywords:  Croton celtidifolius; excitotoxicity; proanthocyanidins-rich fraction; spinal cord injury

Mesh:

Substances:

Year:  2014        PMID: 24438047     DOI: 10.1111/jphp.12177

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  1 in total

1.  Procyanidin Compound (PC) Suppresses Lipopolysaccharide-Induced Cervical Cancer Cell Proliferation Through Blocking the TLR4/NF-κB Pathway.

Authors:  Haiyan Yang; Ziyu Fang; Xiaoli Qu; Xiaoli Zhang; Yifeng Wang
Journal:  Cancer Manag Res       Date:  2020-01-22       Impact factor: 3.989

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.